Management of Hydrops Fetalis

Initial Diagnostic Evaluation

The American College of Obstetricians and Gynecologists recommends performing an indirect Coombs test to verify non-immune etiology and rule out red cell alloimmunization 1, 3, 4
The Society for Maternal-Fetal Medicine suggests conducting detailed fetal sonography, including comprehensive anatomic survey, fetal echocardiography, and assessment for cardiac arrhythmias 1, 2
Measuring middle cerebral artery (MCA) Doppler peak systolic velocity is crucial to evaluate for fetal anemia, which is the critical decision point in the diagnostic algorithm 1
Obtaining fetal karyotype and/or chromosomal microarray analysis is essential, regardless of whether structural anomalies are identified, as aneuploidy confers poor prognosis 1, 3, 4

The Society for Maternal-Fetal Medicine categorizes cases into three management pathways, including treatable etiologies requiring urgent intervention, lethal prognosis cases, and idiopathic or uncertain prognosis cases 5, 6
For treatable etiologies, such as fetal anemia, cardiac arrhythmias, and large pleural effusions, immediate referral to specialized fetal therapy centers is necessary 3, 4, 5
In cases of lethal chromosomal abnormalities or severe structural anomalies incompatible with life, pregnancy termination or comfort care should be offered 5, 6, 7

The American College of Obstetricians and Gynecologists recommends avoiding iatrogenic prematurity, as the gestational age at delivery significantly impacts survival 3, 4, 7
Delivery at tertiary centers with capability to stabilize and treat critically ill neonates is essential for all non-lethal or potentially treatable etiologies 3, 4, 5

Serial maternal blood pressure monitoring is essential to detect mirror syndrome, a form of severe preeclampsia that develops in association with fetal hydrops 3, 5, 6
Monitoring for signs of maternal edema, hypertension, and proteinuria is crucial, and mirror syndrome necessitates delivery in most cases 3, 4, 1

The overall neonatal survival is often less than 50% even in the absence of aneuploidy, and aneuploidy confers particularly poor prognosis 1, 2, 9
Treatable causes, such as fetal arrhythmia and parvovirus B19, have better outcomes, while independent risk factors for death include younger gestational age, low 5-minute Apgar score, and need for high-level respiratory support 7